• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用预测模型优化亨廷顿舞蹈病纹状体内干预的筛查

Optimizing Screening for Intrastriatal Interventions in Huntington's Disease Using Predictive Models.

作者信息

Barrett Matthew J, Negida Ahmed, Mukhopadhyay Nitai, Kim Jin K, Nawaz Huma, Jose Jefin, Testa Claudia

机构信息

Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA.

Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, USA.

出版信息

Mov Disord. 2024 May;39(5):855-862. doi: 10.1002/mds.29749. Epub 2024 Mar 11.

DOI:10.1002/mds.29749
PMID:38465778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11102310/
Abstract

BACKGROUND

Intrastriatal delivery of potential therapeutics in Huntington's disease (HD) requires sufficient caudate and putamen volumes. Currently, volumetric magnetic resonance imaging is rarely done in clinical practice, and these data are not available in large research cohorts such as Enroll-HD.

OBJECTIVE

The objective of this study was to investigate whether predictive models can accurately classify HD patients who exceed caudate and putamen volume thresholds required for intrastriatal therapeutic interventions.

METHODS

We obtained and merged data for 1374 individuals across three HD cohorts: IMAGE-HD, PREDICT-HD, and TRACK-HD/TRACK-ON. We imputed missing data for clinical variables with >72% non-missing values and used the model-building algorithm BORUTA to identify the 10 most important variables. A random forest algorithm was applied to build a predictive model for putamen volume >2500 mm and caudate volume >2000 mm bilaterally. Using the same 10 predictors, we constructed a logistic regression model with predictors significant at P < 0.05.

RESULTS

The random forest model with 1000 trees and minimal terminal node size of 5 resulted in 83% area under the curve (AUC). The logistic regression model retaining age, CAG repeat size, and symbol digit modalities test-correct had 85.1% AUC. A probability cutoff of 0.8 resulted in 5.4% false positive and 66.7% false negative rates.

CONCLUSIONS

Using easily obtainable clinical data and machine learning-identified initial predictor variables, random forest, and logistic regression models can successfully identify people with sufficient striatal volumes for inclusion cutoffs. Adopting these models in prescreening could accelerate clinical trial enrollment in HD and other neurodegenerative disorders when volume cutoffs are necessary enrollment criteria. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

摘要

背景

在亨廷顿舞蹈病(HD)中,向纹状体内递送潜在治疗药物需要足够的尾状核和壳核体积。目前,容积磁共振成像在临床实践中很少进行,并且在诸如Enroll-HD等大型研究队列中无法获得这些数据。

目的

本研究的目的是调查预测模型是否能够准确分类超过纹状体内治疗干预所需尾状核和壳核体积阈值的HD患者。

方法

我们获取并合并了来自三个HD队列(IMAGE-HD、PREDICT-HD和TRACK-HD/TRACK-ON)的1374名个体的数据。我们对非缺失值>72%的临床变量的缺失数据进行了插补,并使用模型构建算法BORUTA来识别10个最重要的变量。应用随机森林算法构建双侧壳核体积>2500 mm和尾状核体积>2000 mm的预测模型。使用相同的10个预测因子,我们构建了一个逻辑回归模型,其中预测因子在P < 0.05时具有显著性。

结果

具有1000棵树且最小终端节点大小为5的随机森林模型的曲线下面积(AUC)为83%。保留年龄、CAG重复长度和符号数字模态测试校正值的逻辑回归模型的AUC为85.1%。概率截断值为0.8时,假阳性率为5.4%,假阴性率为66.7%。

结论

使用易于获得的临床数据以及机器学习识别的初始预测变量,随机森林和逻辑回归模型能够成功识别出具有足够纹状体体积以符合纳入截断标准的人群。当体积截断是必要的纳入标准时,在预筛选中采用这些模型可以加速HD和其他神经退行性疾病的临床试验入组。© 2024作者。《运动障碍》由Wiley Periodicals LLC代表国际帕金森和运动障碍协会出版。

相似文献

1
Optimizing Screening for Intrastriatal Interventions in Huntington's Disease Using Predictive Models.使用预测模型优化亨廷顿舞蹈病纹状体内干预的筛查
Mov Disord. 2024 May;39(5):855-862. doi: 10.1002/mds.29749. Epub 2024 Mar 11.
2
Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE-HD study.纹状体形态与亨廷顿舞蹈病中的额纹状体电生理运动处理相关:一项IMAGE-HD研究。
Brain Behav. 2016 Jul 27;6(12):e00511. doi: 10.1002/brb3.511. eCollection 2016 Dec.
3
Freesurfer Software Update Significantly Impacts Striatal Volumes in the Huntington's Disease Young Adult Study and Will Influence HD-ISS Staging.Freesurfer 软件更新显著影响亨廷顿舞蹈症青年研究中的纹状体体积,并将影响 HD-ISS 分期。
J Huntingtons Dis. 2024;13(1):77-90. doi: 10.3233/JHD-231512.
4
Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.淡漠与认知控制和前驱期亨廷顿病的纹状体体积有关。
J Int Neuropsychol Soc. 2019 May;25(5):462-469. doi: 10.1017/S1355617719000067. Epub 2019 Feb 26.
5
Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease.尾状核头部横截面积分析在亨廷顿病中的应用。
Eur Neurol. 2019;81(1-2):13-18. doi: 10.1159/000499909. Epub 2019 Apr 23.
6
Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.遗传负荷决定了亨廷顿病前症状期手部皮质纹状体通路的萎缩。
Hum Brain Mapp. 2018 Oct;39(10):3871-3883. doi: 10.1002/hbm.24217. Epub 2018 May 24.
7
Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.多模态影像生物标志物在未显症和早期亨廷顿病中的应用:IMAGE-HD 研究 30 个月数据。
Br J Psychiatry. 2016 Jun;208(6):571-8. doi: 10.1192/bjp.bp.114.156588. Epub 2015 Dec 17.
8
A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease.症状性亨廷顿病的纵向扩散张量成像研究。
J Neurol Neurosurg Psychiatry. 2010 Mar;81(3):257-62. doi: 10.1136/jnnp.2007.142786. Epub 2009 Feb 22.
9
Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease.早期有症状的亨廷顿病患者纹状体的扩散加权成像与容积成像对比研究
J Neurol. 2009 Jan;256(1):109-14. doi: 10.1007/s00415-009-0086-0. Epub 2009 Feb 16.
10
Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.在轻度亨廷顿舞蹈症中,磁共振成像显示壳核体积缩小超过尾状核变化。
Ann Neurol. 1992 Jan;31(1):69-75. doi: 10.1002/ana.410310113.

引用本文的文献

1
Recognition of Conus species using a combined approach of supervised learning and deep learning-based feature extraction.使用监督学习和基于深度学习的特征提取相结合的方法识别芋螺种类。
PLoS One. 2024 Dec 9;19(12):e0313329. doi: 10.1371/journal.pone.0313329. eCollection 2024.
2
Machine learning-based radiomics in neurodegenerative and cerebrovascular disease.基于机器学习的神经退行性疾病和脑血管疾病的影像组学
MedComm (2020). 2024 Oct 28;5(11):e778. doi: 10.1002/mco2.778. eCollection 2024 Nov.

本文引用的文献

1
Divergent cognitive trajectories in early stage Huntington's disease: A 3-year longitudinal study.早期亨廷顿病认知轨迹的差异:一项 3 年的纵向研究。
Eur J Neurol. 2023 Jul;30(7):1871-1879. doi: 10.1111/ene.15806. Epub 2023 Apr 14.
2
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities.亨廷顿病的潜在疾病修饰治疗方法:经验教训和未来机遇。
Lancet Neurol. 2022 Jul;21(7):645-658. doi: 10.1016/S1474-4422(22)00121-1.
3
A biological classification of Huntington's disease: the Integrated Staging System.
亨廷顿病的生物学分类:综合分期系统。
Lancet Neurol. 2022 Jul;21(7):632-644. doi: 10.1016/S1474-4422(22)00120-X.
4
Gene Therapy for Huntington's Disease: The Final Strategy for a Cure?亨廷顿舞蹈症的基因治疗:治愈的最终策略?
J Mov Disord. 2022 Jan;15(1):15-20. doi: 10.14802/jmd.21006. Epub 2021 Nov 17.
5
Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease.Enroll-HD:一个用于亨廷顿舞蹈症的综合临床研究平台及全球观察性研究。
Front Neurol. 2021 Aug 18;12:667420. doi: 10.3389/fneur.2021.667420. eCollection 2021.
6
Composite UHDRS Correlates With Progression of Imaging Biomarkers in Huntington's Disease.复合 UHDRS 与亨廷顿病影像学生物标志物的进展相关。
Mov Disord. 2021 May;36(5):1259-1264. doi: 10.1002/mds.28489. Epub 2021 Jan 20.
7
Therapeutic Update on Huntington's Disease: Symptomatic Treatments and Emerging Disease-Modifying Therapies.亨廷顿病的治疗进展:症状治疗和新兴的疾病修饰治疗。
Neurotherapeutics. 2020 Oct;17(4):1645-1659. doi: 10.1007/s13311-020-00891-w.
8
Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders.推进帕金森病和其他神经紊乱的基因治疗、方法和技术。
Neurol Neurochir Pol. 2020;54(3):220-231. doi: 10.5603/PJNNS.a2020.0046. Epub 2020 Jun 18.
9
Robust Markers and Sample Sizes for Multicenter Trials of Huntington Disease.亨廷顿病多中心试验的稳健标志物和样本量。
Ann Neurol. 2020 May;87(5):751-762. doi: 10.1002/ana.25709. Epub 2020 Mar 14.
10
Association of CAG Repeats With Long-term Progression in Huntington Disease.CAG重复序列与亨廷顿病长期进展的关联
JAMA Neurol. 2019 Nov 1;76(11):1375-1385. doi: 10.1001/jamaneurol.2019.2368.